Microglial Drug Targets in AD: Opportunities and Challenges in Drug Discovery and Development

Alzheimer’s disease (AD) is a large and increasing unmet medical need with no disease-modifying treatment currently available. Genetic evidence from genome-wide association studies (GWASs) and gene network analysis has clearly revealed a key role of the innate immune system in the brain, of which mi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Biber, Knut, Bhattacharya, Anindya, Campbell, Brian M., Piro, Justin R., Rohe, Michael, Staal, Roland G.W., Talanian, Robert V., Möller, Thomas
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6716448/
https://ncbi.nlm.nih.gov/pubmed/31507408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00840
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars